Zura Bio Limited Stock Today
| ZURA Stock | 1.12 0.01 0.88% |
PerformanceVery Weak
| Odds Of DistressAbove Average
|
Zura Bio is trading at 1.12 as of the 24th of June 2025, a 0.88 percent down since the beginning of the trading day. The stock's open price was 1.13. Zura Bio has more than 60 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 25th of May 2025 and ending today, the 24th of June 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 3rd of September 2021 | Category Healthcare | Classification Health Care |
Zura Bio is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 61.88 M outstanding shares of which 3.08 M shares are at this time shorted by private and institutional investors with about 5.85 trading days to cover. More on Zura Bio Limited
Moving together with Zura Stock
Moving against Zura Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Zura Stock Highlights
| President COO | Robert Lisicki | |||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
Debt LevelsZura Bio can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Zura Bio's financial leverage. It provides some insight into what part of Zura Bio's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||
Zura Bio Limited (ZURA) is traded on NASDAQ Exchange in USA. It is located in 1489 W. Warm Springs Road, Henderson, NV, United States, 89014 and employs 30 people. Zura Bio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 69.3 M. Zura Bio Limited conducts business under Biotechnology sector and is part of Health Care industry. The entity has 61.88 M outstanding shares of which 3.08 M shares are at this time shorted by private and institutional investors with about 5.85 trading days to cover.
Zura Bio generates negative cash flow from operations
Check Zura Bio Probability Of Bankruptcy
Ownership AllocationZura Bio Limited retains a total of 61.88 Million outstanding shares. The majority of Zura Bio outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Zura Bio Limited to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Zura Bio Limited. Please pay attention to any change in the institutional holdings of Zura Bio Limited as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Zura Ownership Details
Zura Bio Historical Income Statement
Zura Stock Against Markets
Zura Bio Corporate Management
| Gary Whale | Chief Officer | Profile | |
| David Brady | Head Development | Profile | |
| Kiran MBBS | Chief Development | Profile | |
| Kimberly Davis | Chief Secretary | Profile | |
| Theresa Lowry | Chief Officer | Profile | |
| Verender Badial | Chief Officer | Profile |
Already Invested in Zura Bio Limited?
The danger of trading Zura Bio Limited is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zura Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zura Bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zura Bio Limited is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zura Bio Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.